Clinical Trial: A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer
Study Status: ACTIVE_NOT_RECRUITING
Recruit Status: ACTIVE_NOT_RECRUITING
Condition: Prostatic Neoplasms, Castration-Resistant
Study Type: OBSERVATIONAL
Official Title: A Real-World Comparison of Clinical Outcomes in Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer(mCRPC) Patients Who Initiated Enzalutamide vs. Abiraterone Acetate (Abiraterone) in F
Brief Summary:
The purpose of this real-world study is to learn about the effects of 2 study medicines called enzalutamide and abiraterone used to treat metastatic castration-resistant prostate cancer (mCRPC).Prostate cancer is one of the most common cancers in men.The prostate is a gland in the male body that helps make semen.Most prostate cancers need male sex hormones, such as testosterone, to grow.Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels is known as…
Read more